Pharmaceuticals for use in stimulating human blood cell production; Pharmaceuticals for the treatment of cancer. anemia, ischemia, myocardial infarction, congestive heart failure, renal failure; anoxia-induced cellular degeneration; hypoxia-induced cellular degeneration and stroke

Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke

Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke

Pharmaceuticals for use in stimulating human blood cell production; Pharmaceuticals for the treatment of cancer. anemia, ischemia, myocardial infarction, congestive heart failure , renal failure; anoxia-induced cellular degeneration; hypoxia-induced cellular degeneration and stroke